Specimen SS-F-M2-04845 // MULTI-AXIS · IFI-M
CB Co-Expression Series IV-PR-C
Mentha × piperita
Peppermint
Target Trait
3.19×
fold-change
Cooling+Bitter-Attenuation co-activation fold-change
Technical Specifications
SKU
SS-F-M2-04845
Genomic Edits
10
GC Content
48.5%
Construct Length
5,089 bp
Promoter System
Ubiquitin / T7
Expression System
Protoplast PEG-fusion
Host Strain
PEG-mediated
Receptor Target
TRPM8 + TAS2R38 (suppression)
IFI Score
319
Pathway Edits
- TRPM8 pathway primary gene cluster overexpression for cooling axis activation
- TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
- Bidirectional promoter system for synchronized C+B dual-axis co-expression
- Metabolic flux partitioning between IFI-C and IFI-B pathway branches via carbon flow optimization
- Transcription factor co-binding site engineering for Cooling-Bitter-Attenuation combinatorial gene regulation
- Cross-pathway feedback inhibition circuit removal for C+B simultaneous accumulation
- Cofactor balance optimization for C+B dual-pathway operation
- Protein scaffold engineering for C+B enzyme co-localization
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Tier IV CB dual-axis co-expression platform for food ingredient applications requiring verified combined cooling+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.
License
$4149 · Tier IV License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?